Search Results

Surmodics Pounce Thrombectomy Platform Evaluated in Sex-Specific Analysis of PROWL Registry

November 6, 2025—Surmodics, Inc. announced results from a sex-specific analysis of its ongoing PROWL registry evaluating real-world use of the Pounce thrombectomy platform to treat thromboembolic limb ischemia.

PROWL Evaluates Surmodics’s Pounce Thrombectomy Platform in Treatment of Limb Ischemia

November 11, 2025—Surmodics, Inc. announced new real-world results from the PROWL registry evaluating the company’s Pounce thrombectomy platform for nonsurgical removal of emboli and thrombi in the peripheral arterial vasculature.

Boston Scientific’s Ekos System Compared With Mechanical Thrombectomy in REAL-PE Study

October 24, 2023—Boston Scientific announced that data from the REAL-PE study demonstrated that patients treated for pulmonary embolism (PE) with the company’s Ekos endovascular system had lower rates of adverse events, including statistically significant lower rates of major bleeding, within 7 days after their procedure compared to the Inari FlowTriever system (Inari Medical, Inc).

Medtronic’s FlowMet Peripheral Blood Flow Monitoring System With a Disposable Sensor Now Available in United States

July 30, 2021—Medtronic announced that the FlowMet peripheral blood flow monitoring system with a disposable sensor is now available in the United States.

RapidAI’s Rapid RV/LV Cleared by FDA as Part of Its PE Care Solution

February 22, 2023—RapidAI, a company focused on artificial intelligence (AI)–enhanced clinical decision support and patient workflow products for neurovascular and vascular treatment, announced it has received FDA 510(k) clearance for a new tool that allows physicians to quickly assess the ratio between the right ventricle (RV) and the left ventricle (LV) to determine severity of pulmonary embolism (PE), known as Rapid RV/LV.